Drug safety. Heart attack risk overshadows a popular diabetes therapy. [electronic resource]
Producer: 20070629Description: 1550-1 p. digitalISSN:- 1095-9203
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Clinical Trials as Topic
- Diabetes Mellitus -- drug therapy
- Drug Industry
- Humans
- Hypoglycemic Agents -- adverse effects
- Meta-Analysis as Topic
- Myocardial Infarction -- chemically induced
- Risk
- Risk Factors
- Rosiglitazone
- Thiazolidinediones -- adverse effects
- Triglycerides -- blood
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.